Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $27.36M.
ENTERPRISE VALUE (EV)
$27.36M
Elicio Therapeutics, Inc.
Market Cap
$36.51M
Enterprise Value (EV)
$27.36M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Elicio Therapeutics, Inc. (ELTX) | $36.51M | $27.36M |
| Nephros, Inc. (NEPH)vs › | $36.37M | $32.54M |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.28M | $29.64M |
| Edesa Biotech, Inc. (EDSA)vs › | $37.09M | $26.76M |
| DocGo Inc. (DCGO)vs › | $35.77M | $36.44M |
| EUDA Health Holdings Limited (EUDA)vs › | $35.71M | $37.76M |
| Incannex Healthcare Limited (IXHL)vs › | $37.83M | N/A |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.06M | $28.18M |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.58M | $20.83M |
| Accuray Incorporated (ARAY)vs › | $34.21M | $177.47M |
Market Cap
$36.51M
Total Debt
$9.41M
Cash
$18.56M
Enterprise Value
$27.36M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
